<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Pipeline | Novascope BioChips</title>
<meta name="description" content="Novascope BioChips Pipeline — 98% accuracy in sepsis detection, NfL R²=0.97-0.99 vs SIMOA, biomarker portfolio across infectious disease, neurodegeneration, oncology.">
<meta property="og:title" content="Pipeline | Novascope BioChips">
<meta property="og:description" content="Novascope BioChips Pipeline — 98% accuracy in sepsis detection, NfL R²=0.97-0.99 vs SIMOA, biomarker portfolio across infectious disease, neurodegeneration, oncology.">
<meta property="og:type" content="website">
<meta property="og:site_name" content="Novascope BioChips">
<link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=DM+Mono:wght@400;500&family=DM+Sans:wght@400;500;600;700&family=Playfair+Display:wght@400;600;700;800&display=swap" rel="stylesheet">
<link rel="stylesheet" href="styles.css">
<noscript><style>.fo{opacity:1;transform:none}</style></noscript>
</head>
<body>
<script>if(sessionStorage.getItem('nova_auth')!=='1'){window.location.href='login.html';}</script>
<a href="#main" class="skip-link">Skip to content</a>

<!-- Navigation — 5+1 pattern with dropdowns -->
<nav class="nav" role="navigation" aria-label="Main navigation">
<div class="nav-inner">
<a href="home.html"><img id="nav-logo" class="nav-logo" alt="Novascope BioChips" src=""></a>
<div class="nav-links">
<div class="nav-dropdown">
<a href="technology.html" class="nav-link">Science <svg viewBox="0 0 12 12"><path d="M2 4l4 4 4-4" fill="none" stroke="currentColor" stroke-width="1.5"/></svg></a>
<div class="nav-dropdown-menu">
<a href="technology.html" class="dropdown-item">Technology Platform</a>
<a href="technology.html#ip" class="dropdown-item">IP &amp; Patents</a>
</div>
</div>
<a href="pipeline.html" class="nav-link active">Pipeline</a>
<a href="solutions.html" class="nav-link">Products</a>
<div class="nav-dropdown">
<a href="about.html" class="nav-link">Company <svg viewBox="0 0 12 12"><path d="M2 4l4 4 4-4" fill="none" stroke="currentColor" stroke-width="1.5"/></svg></a>
<div class="nav-dropdown-menu">
<a href="about.html" class="dropdown-item">About Us</a>
<a href="about.html#team" class="dropdown-item">Team</a>
<a href="partners.html" class="dropdown-item">Partners</a>
<a href="news.html" class="dropdown-item">News &amp; Events</a>
</div>
</div>
<a href="investors.html" class="nav-link">Investors</a>
</div>
<a href="contact.html" class="nav-cta desktop-only">Contact IR</a>
<button class="hamburger" aria-label="Menu"><span></span><span></span><span></span></button>
</div>
<div class="mobile-menu">
<a href="home.html" class="nav-link">Home</a>
<span class="mobile-dropdown-title">Science</span>
<a href="technology.html" class="dropdown-item">Technology Platform</a>
<a href="technology.html#ip" class="dropdown-item">IP &amp; Patents</a>
<a href="pipeline.html" class="nav-link active">Pipeline</a>
<a href="solutions.html" class="nav-link">Products</a>
<span class="mobile-dropdown-title">Company</span>
<a href="about.html" class="dropdown-item">About Us</a>
<a href="about.html#team" class="dropdown-item">Team</a>
<a href="partners.html" class="dropdown-item">Partners</a>
<a href="news.html" class="dropdown-item">News &amp; Events</a>
<a href="investors.html" class="nav-link">Investors</a>
<a href="contact.html" class="nav-link nav-cta">Contact IR</a>
</div>
</nav>

<!-- Hero — 98% Accuracy Impact Stat -->
<section id="main" class="hero">
<div class="hero-grid"></div>
<div class="hero-glow"></div>
<div class="container" style="position:relative;z-index:1">
<div class="label fo">Clinical Validation Breakthrough</div>
<h1 class="fo fo-d1" style="display:flex;align-items:baseline;gap:20px;flex-wrap:wrap"><span style="font-family:var(--fm);font-size:clamp(3rem,8vw,5.5rem);color:var(--bio-light);letter-spacing:-0.03em;line-height:1">98%</span> <span>Accuracy in<br>Sepsis Detection</span></h1>
<p class="fo fo-d2" style="margin-top:16px">Technology de-risked, performance proven. Third-party validated clinical data from IRB-approved protocols at Chang Gung Memorial Hospital.</p>
<div class="metrics fo fo-d3">
<div class="metric"><div class="metric-val">97%</div><div class="metric-label">Sensitivity</div></div>
<div class="metric"><div class="metric-val">100%</div><div class="metric-label">Specificity</div></div>
<div class="metric"><div class="metric-val">10&sup2;</div><div class="metric-label">cfu/mL LOD</div></div>
<div class="metric"><div class="metric-val">&lt;1h</div><div class="metric-label">Turnaround</div></div>
</div>
<div class="badges fo fo-d4">
<div class="badge"><svg viewBox="0 0 24 24"><path d="M9 12l2 2 4-4"/><circle cx="12" cy="12" r="10"/></svg> IRB-Approved</div>
<div class="badge"><svg viewBox="0 0 24 24"><path d="M9 12l2 2 4-4"/><circle cx="12" cy="12" r="10"/></svg> n=88 Clinical Samples</div>
<div class="badge"><svg viewBox="0 0 24 24"><path d="M9 12l2 2 4-4"/><circle cx="12" cy="12" r="10"/></svg> CGMH Validated</div>
</div>
</div>
</section>

<!-- Section Nav — Sticky -->
<nav class="section-nav" id="section-nav" aria-label="Page sections">
<div class="section-nav-inner">
<a href="#sepsis" class="section-nav-link active" data-section="sepsis">Sepsis</a>
<a href="#alzheimers" class="section-nav-link" data-section="alzheimers">Alzheimer&rsquo;s</a>
<a href="#competitive" class="section-nav-link" data-section="competitive">Competitive</a>
<a href="#regulatory" class="section-nav-link" data-section="regulatory">Regulatory</a>
</div>
</nav>

<!-- ============================================================
     SEPSIS — Lead Indication
     ============================================================ -->
<section class="section section-dark" id="sepsis">
<div class="container">
<div class="section-head fo">
<div class="section-label" style="color:var(--bio-light)">Lead Indication</div>
<h2>Sepsis: Direct-from-Blood Bacterial Detection</h2>
<p style="max-width:700px">In third-party clinical validation at Chang Gung Memorial Hospital (CGMH), the NS01 platform achieved breakthrough performance on the hardest clinical challenge &mdash; detecting pathogens directly from uncultured whole blood.</p>
</div>

<!-- Clinical Results -->
<div class="grid-2 fo fo-d1" style="gap:48px;align-items:start">
<div>
<h3 style="margin-bottom:24px">Clinical Validation Results</h3>

<!-- Progress bars -->
<div class="progress-wrap">
<div class="progress-label"><span style="color:var(--w)">Overall Accuracy</span><span style="color:var(--bio-light);font-family:var(--fm);font-weight:700">98%</span></div>
<div class="progress-bar" style="background:rgba(255,255,255,.1)"><div class="progress-fill" data-width="98%"></div></div>
</div>
<div class="progress-wrap">
<div class="progress-label"><span style="color:var(--w)">Sensitivity</span><span style="color:var(--bio-light);font-family:var(--fm);font-weight:700">97%</span></div>
<div class="progress-bar" style="background:rgba(255,255,255,.1)"><div class="progress-fill" data-width="97%"></div></div>
</div>
<div class="progress-wrap">
<div class="progress-label"><span style="color:var(--w)">Specificity</span><span style="color:var(--bio-light);font-family:var(--fm);font-weight:700">100%</span></div>
<div class="progress-bar" style="background:rgba(255,255,255,.1)"><div class="progress-fill" data-width="100%"></div></div>
</div>
<div class="progress-wrap">
<div class="progress-label"><span style="color:var(--w)">PPV</span><span style="color:var(--bio-light);font-family:var(--fm);font-weight:700">100%</span></div>
<div class="progress-bar" style="background:rgba(255,255,255,.1)"><div class="progress-fill" data-width="100%"></div></div>
</div>
<div class="progress-wrap">
<div class="progress-label"><span style="color:var(--w)">NPV</span><span style="color:var(--bio-light);font-family:var(--fm);font-weight:700">91%</span></div>
<div class="progress-bar" style="background:rgba(255,255,255,.1)"><div class="progress-fill" data-width="91%"></div></div>
</div>

<p style="font-size:.75rem;margin-top:16px;color:rgba(255,255,255,.4)">Non-cultured clinical whole blood samples. 88 clinical samples, LinKou CGMH hospital. Single-center, IRB-approved protocol. Turnaround: &lt;1h vs 2&ndash;5 days culture.</p>

<!-- Confusion Matrices -->
<div style="margin-top:32px">
<h4 style="margin-bottom:16px;font-size:.9rem">Third-Party Validation &mdash; Confusion Matrices</h4>
<div class="grid-2" style="gap:16px">
<div>
<div style="font-family:var(--fm);font-size:.7rem;color:var(--bio-light);margin-bottom:8px">NON-CULTURED BLOOD</div>
<table class="tbl tbl-dark" style="font-size:.8rem">
<tr><th></th><th>Actual +</th><th>Actual &minus;</th></tr>
<tr><td><strong>Chip +</strong></td><td style="color:var(--g);font-weight:700">TP = 33</td><td>FP = 0</td></tr>
<tr><td><strong>Chip &minus;</strong></td><td>FN = 1</td><td style="color:var(--g);font-weight:700">TN = 10</td></tr>
</table>
</div>
<div>
<div style="font-family:var(--fm);font-size:.7rem;color:var(--gold-light);margin-bottom:8px">POST-CULTURE BLOOD</div>
<table class="tbl tbl-dark" style="font-size:.8rem">
<tr><th></th><th>Actual +</th><th>Actual &minus;</th></tr>
<tr><td><strong>Chip +</strong></td><td style="color:var(--g);font-weight:700">TP = 33</td><td>FP = 1</td></tr>
<tr><td><strong>Chip &minus;</strong></td><td>FN = 1</td><td style="color:var(--g);font-weight:700">TN = 9</td></tr>
</table>
</div>
</div>
</div>
</div>

<div>
<div class="img-frame" style="border-color:rgba(255,255,255,.1)">
<img data-img="SEPSIS" alt="Sepsis detection chip results">
<div class="img-caption" style="background:var(--d2);color:rgba(255,255,255,.5)">Direct-from-whole-blood detection results</div>
</div>
<div class="img-frame" style="margin-top:16px;border-color:rgba(255,255,255,.1)">
<img data-img="CLINICAL_BREAKTHROUGH" alt="Clinical validation breakthrough">
<div class="img-caption" style="background:var(--d2);color:rgba(255,255,255,.5)">Clinical validation breakthrough: 98% accuracy in sepsis detection</div>
</div>

<!-- Key stats -->
<div style="display:grid;grid-template-columns:1fr 1fr;gap:12px;margin-top:16px">
<div class="card card-dark" style="padding:16px;text-align:center">
<div style="font-family:var(--fm);font-size:1.5rem;font-weight:700;color:var(--r)">10&sup2;</div>
<div style="font-size:.7rem;color:rgba(255,255,255,.5)">cfu/mL LOD</div>
</div>
<div class="card card-dark" style="padding:16px;text-align:center">
<div style="font-family:var(--fm);font-size:1.5rem;font-weight:700;color:var(--r)">1,000&times;</div>
<div style="font-size:.7rem;color:rgba(255,255,255,.5)">vs BioFire sensitivity</div>
</div>
</div>
</div>
</div>
</div>
</section>

<!-- ============================================================
     ALZHEIMER'S — Neurodegeneration
     ============================================================ -->
<section class="section" id="alzheimers">
<div class="container">
<div class="section-head fo">
<div class="section-label">Neurodegeneration</div>
<h2>Alzheimer&rsquo;s Disease: Head-to-Head vs SIMOA</h2>
<p style="max-width:700px">Across three independent batches testing NfL in clinical samples, Novascope achieved R&sup2; values of 0.97&ndash;0.99 against the Quanterix SIMOA platform (SIMOA self-correlation: 0.98&ndash;0.99). Matching the $300,000 gold standard on a desktop platform.</p>
</div>

<div class="grid-2 fo fo-d1" style="align-items:start;gap:48px">
<div>
<h4 style="margin-bottom:16px">NfL Correlation Data</h4>
<div class="img-frame">
<img data-img="CORRELATION" alt="NfL correlation Novascope vs SIMOA">
<div class="img-caption">NfL cross-platform correlation: Novascope vs Quanterix SIMOA &mdash; R&sup2; = 0.97&ndash;0.99</div>
</div>
<div class="img-frame" style="margin-top:16px">
<img data-img="AD" alt="Alzheimer's biomarker panel">
<div class="img-caption">Alzheimer&rsquo;s disease biomarker detection panel</div>
</div>
</div>
<div>
<h4 style="margin-bottom:16px">Neurodegeneration Biomarker Panel</h4>
<div class="tbl-wrap">
<table class="tbl" style="font-size:.8rem">
<thead>
<tr><th>Biomarker</th><th>Status</th><th>Application</th></tr>
</thead>
<tbody>
<tr class="highlight"><td><strong>NfL</strong></td><td style="color:var(--g);font-weight:600">Validated (R&sup2;=0.97&ndash;0.99)</td><td>Pan-neurodegeneration</td></tr>
<tr><td><strong>p-Tau 217</strong></td><td style="color:var(--gold-light);font-weight:600">In Development</td><td>AD-specific &mdash; key differentiator</td></tr>
<tr><td><strong>p-Tau 231</strong></td><td style="color:var(--gold-light);font-weight:600">In Development</td><td>AD staging</td></tr>
<tr><td>p-Tau 181</td><td style="color:var(--gold-light)">In Development</td><td>AD screening</td></tr>
<tr><td>GFAP</td><td style="color:var(--gold-light)">In Development</td><td>Astrocyte activation</td></tr>
<tr><td>A&beta; 42/40</td><td style="color:var(--txt3)">Pipeline</td><td>Amyloid pathology ratio</td></tr>
<tr><td>TDP-43</td><td style="color:var(--txt3)">Pipeline</td><td>FTD, ALS</td></tr>
<tr><td>&alpha;-Synuclein</td><td style="color:var(--txt3)">Pipeline</td><td>Parkinson&rsquo;s, LBD</td></tr>
<tr><td>S100B</td><td style="color:var(--txt3)">Pipeline</td><td>Brain injury marker</td></tr>
<tr><td>UCH-L1</td><td style="color:var(--txt3)">Pipeline</td><td>Traumatic brain injury</td></tr>
</tbody>
</table>
</div>

<div style="margin-top:24px;padding:20px;background:rgba(139,92,246,.05);border:1px solid rgba(139,92,246,.15);border-radius:var(--r2)">
<h4 style="color:#8B5CF6;font-size:.9rem;margin-bottom:8px">Market Catalyst: AD Drug Revolution</h4>
<p style="font-size:.85rem">Lecanemab (Leqembi) at $26,500/year creates mandatory biomarker screening demand. Current PET/CSF testing: $500&ndash;$1,250 at reference labs only. 6M+ Americans with AD need affordable, decentralized biomarker testing. Novascope target: ~$200/test at a local clinic.</p>
</div>
</div>
</div>

<!-- IHC Gallery — 4 best images, 2x2 grid -->
<div class="fo fo-d2" style="margin-top:48px">
<h4 style="margin-bottom:16px">IHC Brain Tissue Gallery &mdash; Antibody Validation</h4>
<p style="font-size:.85rem;margin-bottom:16px;color:var(--txt2)">The ultimate specificity validation: testing neurological antibodies against human brain tissue from Alzheimer&rsquo;s disease patients using immunohistochemistry &mdash; the gold standard. Independent researchers confirmed staining patterns match published references.</p>
<div class="ihc-gallery" style="grid-template-columns:repeat(2,1fr);max-width:640px">
<div class="ihc-item"><img data-img="IHC_PTAU217" alt="IHC pTau-217 staining"><div class="ihc-label">p-Tau 217</div></div>
<div class="ihc-item"><img data-img="IHC_NFL" alt="IHC NfL staining"><div class="ihc-label">NfL</div></div>
<div class="ihc-item"><img data-img="IHC_GFAP" alt="IHC GFAP staining"><div class="ihc-label">GFAP</div></div>
<div class="ihc-item"><img data-img="IHC_PTAU231" alt="IHC pTau-231 staining"><div class="ihc-label">p-Tau 231</div></div>
</div>
</div>
</div>
</section>

<!-- ============================================================
     COMPETITIVE IVD LANDSCAPE
     ============================================================ -->
<section class="section section-alt" id="competitive">
<div class="container">
<div class="section-head fo" style="text-align:center">
<div class="section-label">Competitive Landscape</div>
<h2>Competitive IVD Landscape (Nucleic Acid)</h2>
</div>

<div class="fo fo-d1 tbl-wrap">
<table class="tbl" style="font-size:.78rem">
<thead>
<tr><th>Specification</th><th>BioFire BCID2</th><th>T2 Bacteria</th><th>Roche Eplex</th><th>Vivalytic (BOSCH)</th><th style="background:var(--bio)">NOVASCOPE</th></tr>
</thead>
<tbody>
<tr><td><strong>Technology</strong></td><td>Multiplex PCR</td><td>T2MR</td><td>AC Voltammetry</td><td>Multiplex PCR</td><td class="highlight"><strong>FET / BioIC</strong></td></tr>
<tr><td><strong>Specimen</strong></td><td>Positive blood culture</td><td>Whole blood</td><td>Positive blood culture</td><td>Various</td><td class="highlight"><strong>Whole blood (direct)</strong></td></tr>
<tr><td><strong>Pathogens</strong></td><td>43</td><td>6</td><td>55</td><td>Variable</td><td class="highlight"><strong>7 + 10 AMR genes</strong></td></tr>
<tr><td><strong>Reaction time</strong></td><td>~1 hour</td><td>3&ndash;5 hours</td><td>~1.5 hours</td><td>~30 min</td><td class="highlight"><strong>&lt;60 min</strong></td></tr>
<tr><td><strong>Incubation req.</strong></td><td>12&ndash;24h culture</td><td>None</td><td>12&ndash;24h culture</td><td>None</td><td class="highlight"><strong>None</strong></td></tr>
<tr><td><strong>Total testing</strong></td><td>13&ndash;25 hours</td><td>3&ndash;5 hours</td><td>13&ndash;25 hours</td><td>~30 min</td><td class="highlight"><strong>&lt;60 min</strong></td></tr>
<tr><td><strong>LOD</strong></td><td>5&times;10&sup5; cfu/mL</td><td>Variable</td><td>Variable</td><td>Variable</td><td class="highlight"><strong>10&sup2; cfu/mL</strong></td></tr>
<tr><td><strong>AMR genes</strong></td><td>10</td><td>No</td><td>4</td><td>Variable</td><td class="highlight"><strong>10</strong></td></tr>
<tr><td><strong>2024 Revenue</strong></td><td>&euro;1,494M</td><td>$8.3M</td><td>~$50M+</td><td>N/A</td><td class="highlight">Pre-revenue</td></tr>
</tbody>
</table>
</div>
<p style="font-size:.7rem;color:var(--txt3);margin-top:12px;text-align:center">Competitor data from publicly available sources. Novascope data from internal clinical validation. Source: Company filings, press releases.</p>

<!-- Biomarker Portfolio Table -->
<div class="fo fo-d2" style="margin-top:48px">
<h4 style="margin-bottom:16px;text-align:center">Biomarker Portfolio Under Development</h4>
<div class="tbl-wrap">
<table class="tbl">
<thead>
<tr><th>Field</th><th>Infectious Disease</th><th>Neurodegeneration</th><th>Oncology</th><th>Veterinary</th></tr>
</thead>
<tbody>
<tr><td><strong>Probe Type</strong></td><td>NA (Nucleic Acid)</td><td>Ab &amp; NA</td><td>NA</td><td>Ab &amp; NA</td></tr>
<tr><td><strong>Biomarker Probes</strong></td>
<td style="font-size:.8rem">E. faecium, A. baumannii, K. pneumoniae, E. coli, E. faecalis, P. aeruginosa, S. aureus + AMR genes (CTX-M, IMP, KPC, mcr-1a, mecA/C, VIM, NDM, OXA-48)</td>
<td style="font-size:.8rem">NfL, p-Tau 181, p-Tau 217, p-Tau 231, GFAP, A&beta; 42/40, TDP-43, &alpha;-Synuclein, S100B, UCH-L1</td>
<td style="font-size:.8rem">EGFR (168 actionable mutations), liquid biopsy panel</td>
<td style="font-size:.8rem">Veterinary pathogen panel, companion animal diagnostics</td>
</tr>
<tr><td><strong>Status</strong></td>
<td><span style="background:var(--g);color:var(--w);padding:2px 8px;border-radius:10px;font-size:.7rem;font-weight:600">Validated</span></td>
<td><span style="background:var(--gold);color:var(--w);padding:2px 8px;border-radius:10px;font-size:.7rem;font-weight:600">In Development</span></td>
<td><span style="background:var(--txt3);color:var(--w);padding:2px 8px;border-radius:10px;font-size:.7rem;font-weight:600">Pipeline</span></td>
<td><span style="background:var(--txt3);color:var(--w);padding:2px 8px;border-radius:10px;font-size:.7rem;font-weight:600">Pipeline</span></td>
</tr>
</tbody>
</table>
</div>
</div>

<div class="fo fo-d3" style="margin-top:32px">
<div class="grid-2" style="gap:24px">
<div class="img-frame"><img data-img="LANDSCAPE" alt="Competitive IVD landscape visual"><div class="img-caption">Competitive landscape &mdash; pathogen detection technologies</div></div>
<div class="img-frame"><img data-img="COMPETITOR" alt="Competitor comparison"><div class="img-caption">Technology comparison across IVD platforms</div></div>
</div>
</div>
</div>
</section>

<!-- ============================================================
     REGULATORY ROADMAP
     ============================================================ -->
<section class="section" id="regulatory">
<div class="container">
<div class="section-head fo" style="text-align:center">
<div class="section-label">Regulatory</div>
<h2>Regulatory Roadmap 2025&ndash;2028</h2>
<p style="margin:12px auto 0;max-width:650px">Strategic dual-track approach: securing Class I registration while advancing Class II clinical validation for sepsis diagnostics.</p>
</div>

<!-- Timeline SVG -->
<div class="fo fo-d1" style="margin-bottom:40px">
<svg viewBox="0 0 900 280" style="width:100%;max-width:900px;margin:0 auto;display:block" xmlns="http://www.w3.org/2000/svg">
<!-- Timeline axis -->
<line x1="50" y1="140" x2="850" y2="140" stroke="#0D9488" stroke-width="2"/>

<!-- Year markers -->
<circle cx="100" cy="140" r="8" fill="#0D9488"/><text x="100" y="170" text-anchor="middle" fill="var(--txt)" font-family="DM Mono,monospace" font-size="11" font-weight="700">2025</text>
<circle cx="300" cy="140" r="8" fill="#0D9488"/><text x="300" y="170" text-anchor="middle" fill="var(--txt)" font-family="DM Mono,monospace" font-size="11" font-weight="700">2026</text>
<circle cx="500" cy="140" r="8" fill="#B45309"/><text x="500" y="170" text-anchor="middle" fill="var(--txt)" font-family="DM Mono,monospace" font-size="11" font-weight="700">2027</text>
<circle cx="700" cy="140" r="8" fill="#B45309"/><text x="700" y="170" text-anchor="middle" fill="var(--txt)" font-family="DM Mono,monospace" font-size="11" font-weight="700">2028</text>

<!-- 2025: Platform Foundation -->
<rect x="50" y="40" width="200" height="70" rx="8" fill="rgba(13,148,136,.06)" stroke="rgba(13,148,136,.3)" stroke-width="1"/>
<text x="150" y="60" text-anchor="middle" fill="#0D9488" font-family="DM Mono,monospace" font-size="8" font-weight="700">PLATFORM FOUNDATION</text>
<text x="150" y="75" text-anchor="middle" fill="var(--txt2)" font-family="DM Sans,sans-serif" font-size="8">3rd-party verification</text>
<text x="150" y="88" text-anchor="middle" fill="var(--txt2)" font-family="DM Sans,sans-serif" font-size="8">E. coli chip finalized</text>
<text x="150" y="101" text-anchor="middle" fill="var(--g)" font-family="DM Sans,sans-serif" font-size="8" font-weight="600">COMPLETED</text>

<!-- 2026: Dual-Track -->
<rect x="225" y="40" width="200" height="70" rx="8" fill="rgba(13,148,136,.06)" stroke="rgba(13,148,136,.3)" stroke-width="1"/>
<text x="325" y="60" text-anchor="middle" fill="#0D9488" font-family="DM Mono,monospace" font-size="8" font-weight="700">DUAL-TRACK EXECUTION</text>
<text x="325" y="75" text-anchor="middle" fill="var(--txt2)" font-family="DM Sans,sans-serif" font-size="8">Class I TFDA registration</text>
<text x="325" y="88" text-anchor="middle" fill="var(--txt2)" font-family="DM Sans,sans-serif" font-size="8">Class II preclinical verification</text>
<text x="325" y="101" text-anchor="middle" fill="#D97706" font-family="DM Sans,sans-serif" font-size="8" font-weight="600">IN PROGRESS</text>

<!-- Track A: Class I -->
<rect x="200" y="190" width="250" height="40" rx="6" fill="rgba(13,148,136,.08)" stroke="rgba(13,148,136,.2)" stroke-width="1"/>
<text x="325" y="205" text-anchor="middle" fill="#0D9488" font-family="DM Mono,monospace" font-size="8" font-weight="700">Track A: Class I (TFDA)</text>
<text x="325" y="220" text-anchor="middle" fill="var(--txt2)" font-family="DM Sans,sans-serif" font-size="7">QMS &#8594; Registration &#8594; Market Entry</text>

<!-- 2027-2028: Clinical & Launch -->
<rect x="425" y="40" width="200" height="70" rx="8" fill="rgba(180,83,9,.06)" stroke="rgba(180,83,9,.3)" stroke-width="1"/>
<text x="525" y="60" text-anchor="middle" fill="#B45309" font-family="DM Mono,monospace" font-size="8" font-weight="700">CLINICAL TRIALS</text>
<text x="525" y="75" text-anchor="middle" fill="var(--txt2)" font-family="DM Sans,sans-serif" font-size="8">Clinical validation studies</text>
<text x="525" y="88" text-anchor="middle" fill="var(--txt2)" font-family="DM Sans,sans-serif" font-size="8">FDA submission preparation</text>

<rect x="625" y="40" width="200" height="70" rx="8" fill="rgba(180,83,9,.06)" stroke="rgba(180,83,9,.3)" stroke-width="1"/>
<text x="725" y="60" text-anchor="middle" fill="#B45309" font-family="DM Mono,monospace" font-size="8" font-weight="700">FIRST REGULATED PRODUCT</text>
<text x="725" y="75" text-anchor="middle" fill="var(--txt2)" font-family="DM Sans,sans-serif" font-size="8">TFDA Class II approval</text>
<text x="725" y="88" text-anchor="middle" fill="var(--txt2)" font-family="DM Sans,sans-serif" font-size="8">US FDA pathway</text>

<!-- Track B: Class II -->
<rect x="350" y="190" width="400" height="40" rx="6" fill="rgba(180,83,9,.08)" stroke="rgba(180,83,9,.2)" stroke-width="1"/>
<text x="550" y="205" text-anchor="middle" fill="#B45309" font-family="DM Mono,monospace" font-size="8" font-weight="700">Track B: Class II (TFDA &#8594; US FDA)</text>
<text x="550" y="220" text-anchor="middle" fill="var(--txt2)" font-family="DM Sans,sans-serif" font-size="7">Preclinical Spec &#8594; Clinical Trials &#8594; Regulatory Approval &#8594; Launch</text>
</svg>
</div>

<div class="fo fo-d2">
<div class="grid-2" style="gap:24px">
<div class="img-frame">
<img data-img="ROADMAP_BOARD" alt="Regulatory development roadmap">
<div class="img-caption">Regulatory development roadmap &mdash; dual-track strategy for Class I &amp; Class II</div>
</div>
<div class="img-frame">
<img data-img="DUALTRACK" alt="Dual-track regulatory execution">
<div class="img-caption">2026 dual-track regulatory strategy execution timeline</div>
</div>
</div>
</div>

<p style="font-size:.7rem;color:var(--txt3);margin-top:16px;text-align:center;font-style:italic">Products referenced are for Research Use Only (RUO). Not for use in diagnostic procedures unless otherwise specified. Clinical data from IRB-approved research protocols.</p>
</div>
</section>

<!-- CTA -->
<section class="section section-dark" style="text-align:center;padding:80px 0">
<div class="container fo">
<h2 style="margin-bottom:16px">Partner With Us</h2>
<p style="max-width:600px;margin:0 auto 32px;color:rgba(255,255,255,.7)">98% accuracy. Sub-hour turnaround. Direct-from-blood detection. Technology de-risked and ready for clinical partnership.</p>
<div style="display:flex;gap:16px;justify-content:center;flex-wrap:wrap">
<a href="investors.html" class="btn btn-primary">Investor Relations</a>
<a href="contact.html" class="btn btn-dark">Contact Us</a>
</div>
</div>
</section>

<!-- Footer -->
<footer class="footer">
<div class="container">
<div class="footer-grid">
<div>
<img id="ft-logo" class="footer-logo" alt="Novascope" src="">
<p style="font-size:.85rem;max-width:360px">Where Silicon Meets Biology. Novascope BioChips is building the semiconductor platform that transforms diagnostics.</p>
</div>
<div><h4>Company</h4><ul class="footer-links"><li><a href="about.html">About Us</a></li><li><a href="technology.html">Technology</a></li><li><a href="pipeline.html">Pipeline</a></li><li><a href="solutions.html">Products</a></li></ul></div>
<div><h4>Resources</h4><ul class="footer-links"><li><a href="investors.html">Investors</a></li><li><a href="news.html">News</a></li><li><a href="partners.html">Partners</a></li><li><a href="contact.html">Contact</a></li></ul></div>
<div><h4>Legal</h4><ul class="footer-links"><li><a href="#" onclick="document.getElementById('privacy-modal').style.display='flex';return false">Privacy Policy</a></li><li><a href="#" onclick="document.getElementById('terms-modal').style.display='flex';return false">Terms of Use</a></li><li><a href="investors.html#disclaimers">Forward-Looking Statements</a></li></ul></div>
</div>
<div class="footer-bottom">
<p>&copy; 2026 Novascope BioChips Inc. All rights reserved. Delaware, USA.</p>
<p style="margin-top:4px">FDA Establishment Registration: Registered facility &bull; ISO 13485: Certified quality management system &bull; Patent Notice: Protected by one or more patents</p>
<p style="margin-top:4px">NovaCHIP&trade;, NovaLINK&trade;, NovaBIO&trade;, NovaKIT&trade;, NovaAI&trade;, NovaCRO&trade;, and NVDFlow&trade; are trademarks of Novascope BioChips Inc.</p>
<div class="footer-legal">
<p><strong>Forward-Looking Statements:</strong> This website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied.</p>
<p style="margin-top:8px"><strong>No Solicitation:</strong> Nothing on this website constitutes an offer to sell or solicitation of an offer to buy any securities of Novascope BioChips Inc.</p>
<p style="margin-top:8px"><strong>Research Use Only:</strong> Products referenced herein are for Research Use Only (RUO). Not for use in diagnostic procedures unless otherwise specified.</p>
</div>
</div>
</div>
</footer>

<!-- Privacy Modal -->
<div id="privacy-modal" style="display:none;position:fixed;inset:0;z-index:9999;background:rgba(0,0,0,.6);align-items:center;justify-content:center" onclick="if(event.target===this)this.style.display='none'">
<div style="background:var(--w);border-radius:var(--r3);padding:40px;max-width:600px;max-height:80vh;overflow-y:auto;margin:24px">
<h3>Privacy Policy</h3>
<p style="margin-top:16px;font-size:.85rem">Novascope BioChips Inc. respects your privacy. We collect only information voluntarily provided through contact forms. We do not sell, trade, or otherwise transfer your personal information to third parties. This site uses cookies for analytics purposes only. For inquiries: <a href="mailto:privacy@novascopedx.com">privacy@novascopedx.com</a></p>
<button class="btn btn-primary" style="margin-top:20px" onclick="this.closest('div[id]').style.display='none'">Close</button>
</div>
</div>

<!-- Terms Modal -->
<div id="terms-modal" style="display:none;position:fixed;inset:0;z-index:9999;background:rgba(0,0,0,.6);align-items:center;justify-content:center" onclick="if(event.target===this)this.style.display='none'">
<div style="background:var(--w);border-radius:var(--r3);padding:40px;max-width:600px;max-height:80vh;overflow-y:auto;margin:24px">
<h3>Terms of Use</h3>
<p style="margin-top:16px;font-size:.85rem">By accessing this website, you agree to these terms. All content is provided for informational purposes only. All intellectual property rights are reserved by Novascope BioChips Inc.</p>
<button class="btn btn-primary" style="margin-top:20px" onclick="this.closest('div[id]').style.display='none'">Close</button>
</div>
</div>

<script src="images.js"></script>
<script>
// Image mapping
(function(){
var I=window.__IMG||{};
document.querySelectorAll('[data-img]').forEach(function(el){
var key=el.getAttribute('data-img');
if(I[key])el.src=I[key];
});
var maps={'nav-logo':I.LOGO_H,'ft-logo':I.LOGO_H};
for(var id in maps){var el=document.getElementById(id);if(el&&maps[id])el.src=maps[id];}
})();

// Scroll animations
var obs=new IntersectionObserver(function(entries){
entries.forEach(function(e){if(e.isIntersecting){e.target.classList.add('vis');obs.unobserve(e.target)}});
},{threshold:0.1,rootMargin:'0px 0px -40px 0px'});
document.querySelectorAll('.fo').forEach(function(el){obs.observe(el)});

// Animated counters
var counterObs=new IntersectionObserver(function(entries){
entries.forEach(function(e){
if(e.isIntersecting){
e.target.querySelectorAll('.count').forEach(function(el){
var target=parseFloat(el.getAttribute('data-count'));
var prefix=el.getAttribute('data-prefix')||'';
var suffix=el.getAttribute('data-suffix')||'';
var isDecimal=target%1!==0;
var duration=1500;var startTime=null;
function animate(ts){
if(!startTime)startTime=ts;
var progress=Math.min((ts-startTime)/duration,1);
var eased=1-Math.pow(1-progress,3);
var current=target*eased;
el.textContent=prefix+(isDecimal?current.toFixed(1):Math.round(current))+(progress<1?'':suffix);
if(progress<1)requestAnimationFrame(animate);
}
requestAnimationFrame(animate);
});
counterObs.unobserve(e.target);
}
});
},{threshold:0.3});
document.querySelectorAll('.counter-group').forEach(function(el){counterObs.observe(el)});

// Progress bar animations
var progObs=new IntersectionObserver(function(entries){
entries.forEach(function(e){
if(e.isIntersecting){
e.target.querySelectorAll('.progress-fill').forEach(function(bar){
bar.style.width=bar.getAttribute('data-width');
});
progObs.unobserve(e.target);
}
});
},{threshold:0.3});
document.querySelectorAll('.progress-wrap').forEach(function(el){progObs.observe(el)});

// Section nav — IntersectionObserver for active state
(function(){
var sectionNav=document.getElementById('section-nav');
if(!sectionNav)return;
var links=sectionNav.querySelectorAll('.section-nav-link');
var sections=[];
links.forEach(function(link){
var id=link.getAttribute('data-section');
var el=document.getElementById(id);
if(el)sections.push({id:id,el:el,link:link});
});
var observer=new IntersectionObserver(function(entries){
entries.forEach(function(entry){
if(entry.isIntersecting){
links.forEach(function(l){l.classList.remove('active')});
var match=sections.find(function(s){return s.id===entry.target.id});
if(match)match.link.classList.add('active');
}
});
},{rootMargin:'-100px 0px -60% 0px'});
sections.forEach(function(s){observer.observe(s.el)});
})();

// Mobile hamburger
document.querySelector('.hamburger')&&document.querySelector('.hamburger').addEventListener('click',function(){
document.querySelector('.mobile-menu').classList.toggle('open');
});
</script>
</body>
</html>